Study of Therapeutic Effects of Sertraline, Flouxetine, Paroxetine and Citalopram in Premature Ejaculation

Comprative Study of Therapeutic Effects of Sertraline, Flouxetine, Paroxetine and Citalopram in Premature Ejaculation

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180401039167N2

Enrollment

480

Registered

2018-06-25

Start date

2018-07-23

Completion date

Unknown

Last updated

2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation. Premature ejaculation

Interventions

Intervention 1: Intervention group: Sertraline will receive 50 mg every 12 hours from Abidi-Tehran Pharmaceutical Company for 8 weeks. Intervention 2: Intervention group: Flouxetine will receive 20 m

Eligibility

Sex/Gender

Male

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Male with Premature Ejaculation Possible at least Once Coitus a Week Age between 20 to 75 years

Exclusion criteria

Exclusion criteria: Norologic Disorder Age Less than 20 and Over 75 Years Psycologic Disorder History of Pelvic Surgery Urinary and Genital Infection

Design outcomes

Primary

Measure	Time frame
Time of Ejaculation ( From Vaginal Entrance to Ejaculation ). Timepoint: The Time of Ejaculation at the Beginning of the Study ( Before the Intervention) and 4 and 8 weeks after the start of Drug. Method of measurement: Measure the time in seconds by the stopwatch by the patient's wife.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBijan Rezakhaniha

Artesh University of Medical Sciences

reza.bijan@yahoo.com+98 21 8609 5072

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026